We are harnessing the immune system to treat neurodegeneration and cancer.
Biotechnology β’ Neurodegenerative disease β’ Neurodegeneration β’ Immuno-neurology
51 - 200
π° $133M Series E on 2018-07
July 24
π‘ Remote β New York
β³ Contract/Temporary
π’ Junior
π‘ Mid-level
π§ QA Engineer (Quality Assurance)
π H1B Visa Sponsor
Google Cloud Platform